:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Authors:	Walter Strobl, Josef Finsterer
Format:	Recurso digital
Language:
Published:	Zenodo 2023
Online Access:	https://doi.org/10.5281/zenodo.10447460
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
by: Josef Finsterer
Published: (2024)

Whether the Opsoclonus Myoclonus Syndrome Is Paraneoplastic or SARS‐CoV‐2–Related Can Be Clarified
by: Josef Finsterer
Published: (2025)

Post‐COVID dysphagia requires exclusion of SARS‐CoV‐2–associated brainstem encephalitis, vasculitis, polyneuritis cranialis, and myositis
by: Josef Finsterer
Published: (2024)

Post-COVID-19 Fatigue among Physicians May Be Due Not Only to SARS-CoV-2 Infection, But Also To Many Other Causes
by: Josef Finsterer
Published: (2024)

Gastrointestinal involvement in neuromuscular disorders
by: Josef Finsterer, et al.
Published: (2024)

Plasmodium Vivax Can Only Be Responsible for GBS if All Other Triggers Have Been Ruled Out
by: Josef Finsterer
Published: (2026)

Before a diagnosis of secondary catatonia due to chronic nitrous oxide use is made, all alternative causes must be ruled out
by: João Gama Marques, et al.
Published: (2025)

Homogeneous ALS Cohorts in Terms of Etiology, onset type, and Vaccination Status Are Required to Assess the Outcome of Their COVID Infection
by: Josef Finsterer
Published: (2025)

Before homozygous NDUFAF5 variants are held responsible for intrauterine death, their pathogenicity must be demonstrated
by: J. Finsterer
Published: (2024)

Chronic Local Pain, Especially Headaches, May Not Be the Only Cause of Depression
by: Josef Finsterer
Published: (2025)

Before Coming to the Conclusion That Inclusion Body Myositis Is a Risk Factor for a Heart Attack, All Influencing Factors Must Be Taken Into Account
by: Josef Finsterer, et al.
Published: (2025)

Brain Pathology in m.3243A>G Carriers
by: Josef Finsterer
Published: (2023)

Treatment of Stroke-Like Episodes Requires NO-Precursors, Avoidance of Mitochondrion Toxic Drugs, and Antiepileptics only When Seizures Occur
by: Josef Finsterer
Published: (2025)

Contiguous Xp21 Deletion Syndrome with Atypical Phenotype Requires Further Clarification Using WES
by: Josef Finsterer
Published: (2025)

Less Social Contact During the Pandemic Could Explain the Lower Prevalence of GBS During This Time
by: Josef Finsterer
Published: (2025)

Muscle Membrane Permeability Determined by 31P‐MRS and DT‐MRI as a Biomarker for the Progression of Becker Muscular Dystrophy
by: Josef Finsterer
Published: (2026)

In Reference to Bilateral Sudden or Chronic Hearing Loss as an Auditory Manifestation of Mitochondrial DNA Mutations
by: Josef Finsterer
Published: (2025)

The Spectrum of Risk Factors for Falls is Broader Than Expected
by: Josef Finsterer
Published: (2025)

Commentary on: Sağlam İ, Aslan R, Akgür SA, Kurtulmuş Y. Abuse of gabapentinoids in individuals with substance use disorders. J Forensic Sci. 2025;70(3):1125–32. doi: 10.1111/1556‐4029.70028
by: Josef Finsterer
Published: (2025)

Pembrolizumab‐Induced Secondary Hypocorticism Manifesting as a Transitory Ischemic Attack
by: Josef Finsterer
Published: (2025)

Fatal Methaemoglobin Intoxication Following Ketamine Infusion in a Depressed MELAS Patient: A Possible Association?
by: Josef Finsterer
Published: (2025)

The Loss and Dysfunction of Smooth Muscle Cells in MELAS Are Not the Only Cause for Gastrointestinal Dysmotility
by: Josef Finsterer
Published: (2026)

COVID‐19 Patients With Neurological Symptoms Require a Neurological Diagnosis and the Establishment of a Causal Relationship
by: Josef Finsterer
Published: (2025)

Pitfalls in Calculating the Incidence of Guillain‐Barre Syndrome During the Pandemic
by: Josef Finsterer
Published: (2025)

Leigh Syndrome Due to the Variant c. 1019T >C in COX15
by: Josef Finsterer
Published: (2025)

Death of a Child With Celiac Disease and Cerebral Bleeding Requires Extensive Post‐Mortem Analysis to Clarify the Underlying Pathophysiology
by: Josef Finsterer
Published: (2025)

Are Insulin and Metformin Really Protective on Amyotrophic Lateral Sclerosis by Blocking the Astrocytic Cx43 Channel?
by: Josef Finsterer
Published: (2025)

Because secondary intestinal pseudo‐obstruction is potentially treatable, its etiology needs to be clarified
by: Josef Finsterer
Published: (2024)

Mitochondrial diabetes plus phenotypes due to the m.3243A > G variant require correlation with heteroplasmy rates
by: Josef Finsterer
Published: (2024)

Sulfasalazine, but not ankylosing spondylitis may be responsible for axonal neuropathy
by: Josef Finsterer
Published: (2024)

Comment on ‘Quantification of Skeletal Muscle at the First Lumbar Level for Prognosis in Amyotrophic Lateral Sclerosis’ by Cao et al.
by: Josef Finsterer
Published: (2025)

Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
by: Kuldeep Singh Patel
Published: (2020)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas, et al.
Published: (2024)

Torsional twist of the SARS ‐ CoV and SARS ‐ CoV ‐2 SUD ‐N and SUD ‐M domains
by: Monica Rosas‐Lemus, et al.
Published: (2025)

Humoral epitope dominance and immune imprinting by SARS ‐ CoV ‐1 and SARS ‐ CoV ‐2 vaccines
by: Deborah L Burnett, et al.
Published: (2026)

Seroprevalence of SARS‐CoV‐2 Antibody Before and After Both Vaccination and Natural Infection in China
by: Yang Guang, et al.
Published: (2025)

Pandemia por SARS-CoV-2
by: Erina Petrera
Published: (2020)

SARS-CoV-2 and Saliva: an update
by: Muniz, Isis de Araújo Ferreira, et al.
Published: (2020)

Structural Immunology of SARS‐CoV‐2
by: Meng Yuan, et al.
Published: (2024)

Demografía y SARS-CoV-2
by: Manuel Ordorica Mellado
Published: (2021)